NOVEL CRYSTAL OF N-[[(5S)-3-[4-(2,6-DIHYDRO-2-METHYLPYRROLO[3,4-C]PYRAZOL-5(4H)-YL)-3-FLUOROPHENYL]-2-OXO-5-OXAZOLIDINYL]METHYL]ACETAMIDE

摘要

The present invention relates to a novel crystal of the Active Pharmaceutical Ingredient (API) N-[[(5S)-3 -[4-(2,6-dihydro-2-methylpyrrolo[3,4-c]pyrazol-5(4H)-yl)-3-fluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide, methods for the preparation of this crystal, pharmaceutical compositions comprising this crystal, and methods of treating a patient with this crystal.